Stocks post big rebound | Facebook surges | Earnings check-in

Strong results from the likes of Facebook led the major stock averages to a big rally.

VIEW IN BROWSER | SUBSCRIBE THU, APR 28, 2022 EVENING BRIEF AS OF THU, APR 28, 2022 • 04:52 ET DJIA 33916.39 +1.85% +614.46 S&P 500 4287.50 +2.47% +103.54 NASDAQ 12871.53 +3.06% +382.60 Most Active DOW NAME LAST CHG %CHG AAPL 163.64 +7.07 +4.52% INTC 46.84 +1.62 +3.58% MSFT 289.63 +6.41 +2.26% S&P 500 NAME LAST CHG %CHG F 14.62 -0.23 -1.55% AAPL 163.64 +7.07 +4.52% FB 205.73 +30.78 +17.59% NASDAQ NAME LAST CHG %CHG AAPL 163.64 +7.07 +4.52% FB 205.73 +30.78 +17.59% AMD 89.64 +4.73 +5.57% EDITOR'S NOTE Technology earnings stole the show Thursday, as strong results from the likes of Facebook led the major stock averages to a big rally.   Facebook parent Meta Platforms surged more than 17%, making it a top gainer on the Nasdaq, after better-than-expected first-quarter earnings.   The mega-cap tech stock was down 48% on the year heading into the results. It still sits 46% below its 52-week high even after Thursday's rally. U.S. stocks posted a "reversal from weakness we saw earlier this week as investors digest ... strong 1Q21 earnings from Tech giants," Goldman Sachs' Chris Hussey said in a note.   More than 80% of S&P 500 companies beat earnings expectations so far, with almost half of the index's components having reported, according to FactSet.  Hannah Miao | CNBC Associate Markets Reporter @HannahMiao_ Watch our live stream for all you need to know to invest smarter. TOP NEWS  Dow jumps 600 points, Nasdaq pops 3% as tech leads comeback rally U.S. GDP fell at a 1.4% pace to start the year as pandemic recovery takes a hit Biden requests $33 billion for Ukraine war; Putin threatens 'lightning fast' retaliation to nations that intervene Meta shares surge nearly 18% after Facebook parent beats earnings estimates Analysts head for the exits on Teladoc as stock plunges more than 40% Biden says he's not considering $50,000 in student loan forgiveness These stocks show pricing power, a look into Q1 earnings results reveals Eli Lilly obesity drug delivers 20% weight loss, bolstering investment case for new therapies The U.S. economy contracted to start the year, but a recession hardly appears imminent Severe hepatitis outbreak in healthy kids possibly linked to adenovirus infection, WHO officials say TOP VIDEO Teladoc Health trading on the story, not the valuation, says Gilman's Jenny Harrington CNBC PRO These ETFs are holding up or even rising during April's market chaos SPECIAL REPORTS More states are switching to flat income taxes. Critics say it's relief for the wealthy 64% of workers would consider quitting if asked to return to the office full-time Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel Digital Products Feedback Privacy Policy © 2022 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS